DCI

TentativeAI MemoPost-earnings T+3

Donaldson

As of 2026-08-31/Post-earnings T+3/Confidence high

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-31 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence

Action

—

Confidence

high

Horizon

—

Key catalyst

Record FY2026 results and FY2027 guidance • 2026-08-26

Base target: $105 / p=55% prob

Biggest risk

The outlook relies partly on Facet contribution and includes meaningful dilution, higher interest expense, expense deleveraging, and continued operational recovery requirements. The industrial segment remains the main execution risk. [#SEC-8K-2026-08-26]

Invalidation

Break below $82 or thesis failure.

What would change my mind?

Record sales, adjusted margin expansion, strong aftermarket growth, Life Sciences momentum, and FY2027 growth guidance support a constructive medium-term case. [#SEC-8K-2026-08-26]

Research note

Recommendation

—

Confidence

high

As of

2026-08-31

Base target

$105

p=55%

Bull target

$115

p=25%

Bear target

$82

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Higher acquisition costs and execution pressure
Facet integration and industrial recovery
Record sales, adjusted margin expansion, strong aftermarket growth, Life Sciences momentum, and FY2027 growth guidance support a constructive medium-term case.

BearKey bullets

Facet integration, leverage, amortization, and higher interest expense could constrain EPS conversion.
Power Generation production inefficiencies and expense deleveraging could limit margin expansion.
Supply-chain constraints continue to pressure organic Aerospace and Defense performance.

WatchKey bullets

Record FY2026 results and FY2027 guidance

Summary

High-level snapshot

Recommendation

Model confidence

high

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $105 (p=55%)

Target spread vs base: +10% / -22%

Scenario probabilities

Bull Target: $115 (p=25%)Base Target: $105 (p=55%)Bear Target: $82 (p=20%)

Commentary

The earnings surprise was positive, but the initial market gain did not fully hold according to Investing.com's reported overall reaction, leaving the post-print signal mixed. Social, options, and employee sentiment data are unavailable. Verified analyst target or estimate revisions remain unavailable, so forward evidence is strong on reported results but only moderate on execution beyond the initial guide. Source: https://www.investing.com/equities/donaldson-comp-inc-earnings

As of 2026-08-31 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Record sales, adjusted margin expansion, strong aftermarket growth, Life Sciences momentum, and FY2027 growth guidance support a constructive medium-term case. [#SEC-8K-2026-08-26]

Bear Case

Drivers

Scannable catalysts and supporting factors

Higher acquisition costs and execution pressure
Facet integration and industrial recovery

Scenarios

Bull Target (Scenario probability)

$115 / p=25% prob

Base Target (Scenario probability)

$105 / p=55% prob

Bear Target (Scenario probability)

$82 / p=20% prob

Analysis 2026-08-31 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.65

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-26
Record FY2026 results and FY2027 guidance
The August 26 release reported Q4 sales of $1.059 billion, up 8.0%, adjusted EPS of $1.15, up 11.7%, and FY2027 guidance for sales growth of 5.5%-9.5% and EPS of $4.22-$4.38, including $0.12 of Facet dilution. [#SEC-8K-2026-08-26] Market coverage reported EPS of $1.15 versus $1.13 forecast and revenue of $1.10 billion versus $1.04 billion forecast. Source: https://www.investing.com/equities/donaldson-comp-inc-earnings
Prob 90.00% • Move 4.00% • Priced-in 80.00%

Short-term Catalysts

Next few weeks

Higher acquisition costs and execution pressure
2026-12-02
Management projects FY2027 interest expense of $55-$60 million versus $36 million in FY2026, while expense deleveraging, amortization, supply-chain constraints, and production inefficiencies remain offsets to margin expansion. The next market-listed earnings checkpoint is December 2, 2026. [#SEC-8K-2026-08-26]
Prob 65% • Move -6% • Priced-in 65%

Long-term Catalysts

Months to a year

Facet integration and industrial recovery
2027-07-31
FY2027 guidance assumes mid-teens Industrial growth, more than 50% Aerospace and Defense growth including Facet, mid-teens organic Aerospace and Defense growth, and operating margin of 16.6%-17.2%. [#SEC-8K-2026-08-26]
Prob 55% • Move 10% • Priced-in 55%

Risks

Facet integration, leverage, amortization, and higher interest expense could constrain EPS conversion.
Power Generation production inefficiencies and expense deleveraging could limit margin expansion.
Supply-chain constraints continue to pressure organic Aerospace and Defense performance.
Weak dust-collection equipment volume remains a risk to Industrial Filtration Solutions.

Peers

Symbol	Summary
ALSN	Same-sector, similar-market-cap comparator from the packet, but not a tight filtration peer.
MOD	Same-sector, similar-market-cap industrial comparator; useful for cyclicality context but business overlap is limited.
PH	Large curated industrial comparator with broader scale; valuation and operating comparison should be treated cautiously.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-31

Loading AI feed…

Symbol

Summary

ALSN

Same-sector, similar-market-cap comparator from the packet, but not a tight filtration peer.

MOD

Same-sector, similar-market-cap industrial comparator; useful for cyclicality context but business overlap is limited.

Large curated industrial comparator with broader scale; valuation and operating comparison should be treated cautiously.